Fig. 2From: Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcomaOverall Survival: Kaplain-Meier overall survival (OS) curves for dogs entered into the clinical trial. Hash marks denote censored observations. Dotted lines delineate the 95Â % confidence interval. (a) Dogs that received toceranib for longer than 1Â week. (b) All dogsBack to article page